Changes in the activity of cdk2 and cdk5 accompany differentiation of rat primary oligodendrocytes

Journal of Cellular Biochemistry

Volumn 68, Issue 1, 1998, Pages 128-137

  Tang, Xue Ming ^a   Strocchi, Paola ^b   Cambi, Franca ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

cdk2; cdk5; Cell cycle; Cyclin dependent kinases; Differentiation; Oligodendrocytes

Indexed keywords

CYCLIN DEPENDENT KINASE; DNA; ENZYME INHIBITOR; PROTEIN P27;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STEM CELL;

EID: 15144350860     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19980101)68:1<128::AID-JCB13>3.0.CO;2-D     Document Type: Article

References (38)

1. Barres B, Schmid R, Sendnter M, Raff M (1993): Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118:283-295.
2. Behar T, McMorris FA, Novotny EA, Barker JL, Dubois-Dalcq M (1988): Growth and differentiation properties of O-2A progenitors purified from rat cerebral hemispheres. J Neurosci Res 21:168-180.
3. Casaccia-Bonnefil P, Tikoo R, Kiyokawa H, Friedrich V, Chao MV, Koff A (1997):Oligodendrocyte precursor differentiation is perturbed in the absence of the cyclin-dependent kinase inhibitor p27 kip1. Genes & Dev 11:2335-2346.
4. Collarini E, Kuhn R, Marshall C, Monuki E, Lemke G, Richardson W (1992): Down-regulation of the POU transcription factor SCIP is an early event in oligodendrocyte differentiation in vitro. Development 116:193-200.
5. Kip1 and the timing of oligodendrocyte differentiation. EMBO J 16:306-317.
6. Eisenbarth G, Walsh F, Nirenburg M (1979): Monoclonal antibodies to a plasma membrane antigen of neurons. Proc Natl Acad Sci USA 76:4913-4916.
7. Gao CY, Zakeri Z, Zhu Y, He HY, Zelenka PS (1997): Expression of cdk5, p35 andcdk5-associated kinase activity in the developing rat lens. Dev Genetics 20:267-275.
8. Gu Y, Rosenblatt J, Morgan D (1992): Cell cycle regulation of cdk2 activity by phosphorylation of Thr 160 and Tyr15. EMBO J 11:3995-4005.
9. Guo-zai Y, Ziff EB (1995): NGF regulates the PC12 cell cycle machinery through specific inhibition of the cdk kinases and induction of cyclin D1. J Neurosci 15:6200-6212.
10. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lassar AB (1995): Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018-1021.
11. Kip1. Cell 85: 721-732.
12. Lee KY, Helbing CC, Choi KS, Johnston RN, Wang JH (1997): Neuronal Cdc2-like kinase (Nclk) binds and phosphorylates the retinoblastoma protein. J Biol Chem 272: 5622-5626.
13. LeVine S, Goldman J (1988) Spatial and temporal patterns of oligodendrocyte differentiation in rat cerebrum and cerebellum. J Comparative Neurol 277:441-455.
14. Lew J, Wang J (1995): Neuronal cdc2-like kinase. TIBS 20:33-36.
15. MacLachlan TK, Sang N, Giordano A (1995): Cyclins, cyclin-dependent kinases and cdk inhibitors: Implications in cell cycle control and cancer. Crit Rev in Eukary Gene Exp 5:127-156.
16. Matsushita M, Matsui H, Itano T, Tomizawa K, Tokuda M, Suwaki H, Wang JH, Osamu H (1995): Developmental changes of cyclin dependent kinase 5 subcellular localization in the rat cerebellum Neuroreport 6:1267-1270.
17. McKinnon R, Matsui T, Dubois-Dalcq M, Aaronson S (1990): FGF modulates the PDGF-driven pathway ofoligodendrocyte development. Neuron 5:603-614.
18. McMorris F, McKinnon R (1996): Regulation of oligodendrocyte development and CNS myelination by growth factors: Prospects for therapy of demyelinating disease. Brain Path 6:313-329.
19. Morgan D (1995): Principles of CDK regulation. Nature 374:131-134.
20. Morgan D (1996): The dynamics of cyclin dependent kinase structure. Curr Opin Cell Biol 6:767-772.
21. Nikolic M, Dudek H, Kwon Y, Ramos Y, Tsai L-H. (1996): The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes & Development 10:816-825.
22. Noble M and Murray K (1984): Purified astrocytes promtoe the in vitro division of a bipotential glial progenitor cell. EMBO J 3:2243-2247.
23. Ohshima T, Ward J, Huh C-G, Longenecker G, Veeranna, Pant H, Brady R, Martin L, Kulkarni A (1996): Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci USA 93:11173-11178.
24. Pardee A (1989): G1 events and regulation of cell proliferation. Science 24:603-608.
25. Pfeiffer SE, Warrington AE, Bansal R (1993): The oligodendrocyte and its cellular processes. Trends Cell Biol 3:191-197.
26. Pringle N, Mudhar H, Collarini E, Richardson W (1992): PDGF receptors in the rat CNS: During late neurogenesis, PDGF alpha-receptor expression appears to be restricted to glial cells of the oligodendrocyte lineage. Development 115:535-551.
27. Raff MC, Mirsky R, Fields KL, Lisak RP, Dorfman SH, Silberberg DH, Gregson NA, Leibowitz S, Kennedy MC (1978): Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in culture. Nature 274:813-816.
28. Raff MC, Miller RH, Noble M (1983): A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture nedium. Nature 303:390-396.
29. Ranscht B, Clapshaw P, Price J, Noble M, and Seifert W (1982): Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside. Proc Natl Acad Sci USA 79:2709-2713.
30. Reysnidottir I, Polyak K, Iavarone A, and Massague J (1995): Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes and Dev 9:1831-1845.
31. kip1 coordinate their inhibitory interactions with cdk4 and cdk2. Genes and Dev 11:492-503.
32. Rus H, Niculescu F, Shin ML (1996): Sublytic complement attack induces cell cycle in oligodendrocytes. J Immunol 4892-4900.
33. Sherr CJ (1994): G1 phase progression: Cycling on cue. Cell 79:551-555.
34. Sherr CJ, Roberts J (1995): Inhibitors of mammalian G1 cyclin-dependent kinases. Genes and Dev 9:1149-1163.
35. Tikoo R, Casaccia-Bonnefil P, Chao MV, and Koff A (1997): Changes in cyclin-dependent kinase 2 and p27kip1 accompany glial cell differentiation of Central Glia 4 cells. J Biol Chem 272:442-447.
36. Tsai L-H, Takahashi T, Caviness V, Harlow E (1993): Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development 119:1029-1040.
37. Van Den Heuvel S, Harlow E (1993): Distinct roles for cyclin-dependent kinanses in cell cycle control. Science 262:2050-2054.
38. Zhang Q, Ahuja HS, Zakeri Z, Wolgelmuth D (1997): Cyclin-dependent kinase 5 is associated with apoptotic cell death during development and tissue remodeling. Dev Biol 183:222-233.